News Industry News FDA approves new treatments for heart disease caused by a serious rare disease, transthyretin mediated amyloidosis May 06, 2019
News Industry News Heart Metabolics Announces Initiation Of Phase 2b Study Of Perhexiline For Hypertrophic Cardiomyopathy August 31, 2016
News Industry News Cardiome Announces Filing of Orphan Drug Application for Oral Vernakalant with U.S. FDA January 26, 2016
News Industry News Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease August 14, 2015
News Industry News A Competitive Analysis of the Global Acute Coronary Syndrome (ACS) Therapeutics Market May 28, 2015
News Industry News Cardiome Announces Commercialization Partnership For BRINAVESS™ In Select European Markets July 03, 2013
News Industry News Heart Metabolics Receives Funding for U.S. Clinical Development of Heart Failure Drug January 02, 2013